Ticker Details
Quidel Corporation Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others.
IPO Date:	February 1, 1991
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$963.36M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.91 | 2.01%
Avg Daily Range (30 D):	$0.62 | 3.55%
Avg Daily Range (90 D):	$0.70 | 2.94%

Institutional Daily Volume
Avg Daily Volume:	.4M
Avg Daily Volume (30 D):	1.45M
Avg Daily Volume (90 D):	1.07M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	5,780
Avg Institutional Trade:	$3.31M
Avg Institutional Trade (30 D):	$2.74M
Avg Institutional Trade (90 D):	$2.95M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.28M
Avg Closing Trade (30 D):	$4.07M
Avg Closing Trade (90 D):	$4.21M
Avg Closing Volume:	80.63K

News

Mar 9, 2026 @ 1:05 PM Rice Hall James Buys QuidelOrtho Stock Source: John Ballard

Mar 2, 2026 @ 2:18 AM QuidelOrtho Corp Director Purchases 10k Shares as ... Source: Adé Hennis

Sep 4, 2025 @ 9:35 PM QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is ... Source: Bragar Eagel & Squire, P.C.

Aug 28, 2025 @ 3:00 AM Lateral Flow Assays Market to Grow at a CAGR of 7.... Source: Wissen Research

Aug 6, 2025 @ 4:18 AM QuidelOrtho (QDEL) Fiscal Q2 EPS Beats Source: Jesterai

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-16.69	$-1.9	$-16.69
Diluted EPS	$-16.69	$-1.9	$-16.69
Revenue	$2.73B	$723.6M	$2.73B
Gross Profit
Net Income / Loss	$-1131.8M	$-130.7M	$-1131.8M
Operating Income / Loss	$-919.2M	$-66.3M	$-919.2M
Cost of Revenue
Net Cash Flow	$71.3M	$71.7M	$71.3M
PE Ratio